Invention Grant
US08669228B2 Glucagon analogs exhibiting enhanced solubility in physiological pH buffers
有权
在生理pH缓冲液中表现出增强的溶解度的胰高血糖素类似物
- Patent Title: Glucagon analogs exhibiting enhanced solubility in physiological pH buffers
- Patent Title (中): 在生理pH缓冲液中表现出增强的溶解度的胰高血糖素类似物
-
Application No.: US12522129Application Date: 2008-01-03
-
Publication No.: US08669228B2Publication Date: 2014-03-11
- Inventor: Richard D. Dimarchi , Maria Dimarchi , Joseph Chabenne
- Applicant: Richard D. Dimarchi , Maria Dimarchi , Joseph Chabenne
- Applicant Address: US IN Indianapolis
- Assignee: Indiana University Research and Technology Corporation
- Current Assignee: Indiana University Research and Technology Corporation
- Current Assignee Address: US IN Indianapolis
- Agency: Barnes & Thornburg LLP
- International Application: PCT/US2008/050099 WO 20080103
- International Announcement: WO2008/086086 WO 20080717
- Main IPC: A61K38/26
- IPC: A61K38/26 ; C07K14/605

Abstract:
Modified glucagon peptides are disclosed having improved solubility while retaining glucagon agonist activity. The glycogen peptides have been modified by substitution of native amino acids with, and/or addition of, charged amino acids to the carboxy terminus of the peptide. The modified glucagon agonists can be further modified by pegylation, or the addition of a carboxy terminal peptide selected from the group consisting of SEQ ID NO: 20, SEQ ID NO: 21, SEQ ID NO: 23, or both to further enhance the solubility of the glucagon agonist analogs.
Public/Granted literature
- US20100190699A1 GLUCAGON ANALOGS EXHIBITING ENHANCED SOLUBILITY IN PHYSIOLOGICAL pH BUFFERS Public/Granted day:2010-07-29
Information query
IPC分类: